There is one clinical trial.
The aims of this study were to (i) assess fear and anxiety of COVID-19 in a Turkish sample dental professionals using the Turkish FCV-19S and CAS; (ii) explore factors associated with FCV-19S and CAS; and (iii) examine the psychometric properties of the Turkish FCV-19S and CAS.
Description: Fear of COVID-19 Scale is an unidimensional scale seven-item scale assessing anxiety regarding COVID-19 developed by Ahorsu et al. Items are rated on a 5-item Likert scale from 1 (Strongly disagree) to 5 (Strongly agree) with scores ranging from 7 to 35. A higher score of the FCV-19S represents a greater level of fear.Measure: The psychosocial effects of COVID-19 pandemic on dental professionals using the Turkish version of the Fear of COVID-19 Scale Time: up to one week
Description: Coronavirus Anxiety Scale is an unidimensional tool that assesses the physiological reactions anxiety related to the COVID-19 pandemic. Participants were asked to rate 5 items on a 5-point Likert-type scale, from 0 (not at all) to 4 (nearly every day over the last 2 weeks).A higher score of CAS represents a greater level of anxiety.Measure: The psychosocial effects of COVID-19 pandemic on dental professionals using the Turkish version of the Coronavirus Anxiety Scale Time: up to one week
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports